Surface-active properties of vasoactive intestinal peptide

被引:15
|
作者
Önyüksel, H
Bodalia, B
Sethi, V
Dagar, S
Rubinstein, I [1 ]
机构
[1] Univ Illinois, Dept Pharmaceut, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Pharmacodynam, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA
[4] Univ Illinois, Dept Med, Chicago, IL 60612 USA
[5] Chicago VA Healthcare Syst, W Side Div, Chicago, IL 60612 USA
关键词
surface tension; monolayer; critical micellar concentration; surfactant; phospholipids; neuropeptides; vasopressin;
D O I
10.1016/S0196-9781(00)00161-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to determine whether human vasoactive intestinal peptide (VIP) aggregates in aqueous solution and, if so, whether the peptide interacts with a biomimetic phospholipid monolayer and increases surface pressure. Using a custom-made Teflon trough containing HEPES buffer (pH 7.4) at room temperature and a surface tensiometer, we found that the critical micellar concentration (CMC) of VIP is 0.4 mu M. Surface pressure of a dipalmitoylphosphatidylcholine (DPPC) monolayer spread over the HEPES buffer declined significantly over 120 min because of phospholipid decomposition. However, injection of VIP at concentrations above CMC into the subphase of the monolayer elicited a significant concentration-dependent increase in surface pressure that persisted for 120 min (P < 0.05). Unlike VIP, injection of [(8)Arg]-vasopressin at an equimolar concentration only prevented the time-dependent decline in DPPC monolayer surface pressure. Taken together, these data indicate that human VIP aggregates in aqueous solution and expresses surface-active properties at physiological concentrations in vitro. We suggest that these attributes could have a role in modulating the bioactive effects of the peptide in vivo. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:419 / 423
页数:5
相关论文
共 50 条
  • [1] Appraisal of surface-active properties and micellization behaviour of imidazolium gemini surfactants
    Kaur, Jaswinder
    Farzeen, Roheela
    Banipal, Tarlok Singh
    Singh, Manpreet
    Lal, Madan
    Yadav, Ajar Nath
    Negi, Rajeshwari
    Upadhyaya, Sanjay Kumar
    Kishore, Kamal
    SUPRAMOLECULAR CHEMISTRY, 2024,
  • [2] The enzymatic modification of phospholipids improves their surface-active properties and the formation of nanoemulsions
    Bravo-Alfaro, Diego A.
    Ochoa-Rodriguez, Laura R.
    Santos-Luna, Dalia
    Villasenor-Ortega, Francisco
    Garcia, Hugo S.
    Luna-Barcenas, Gabriel
    BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, 2023, 48
  • [3] Effect of Surface-Active Agent on Morphology and Properties of Electrospun PVA Nanofibres
    Zhao, Jianghui
    Sun, Zhaoyang
    Shao, Zhongbiao
    Xu, Lan
    FIBERS AND POLYMERS, 2016, 17 (06) : 896 - 901
  • [4] Effect of surface-active agent on morphology and properties of electrospun PVA nanofibres
    Jianghui Zhao
    Zhaoyang Sun
    Zhongbiao Shao
    Lan Xu
    Fibers and Polymers, 2016, 17 : 896 - 901
  • [5] Surface-Active Organics in Atmospheric Aerosols
    McNeill, V. Faye
    Sareen, Neha
    Schwier, Allison N.
    ATMOSPHERIC AND AEROSOL CHEMISTRY, 2014, 339 : 201 - 259
  • [6] Synthesis of mycolic acid biosurfactants and their physical and surface-active properties
    Lee, MJ
    Gwak, HS
    Park, BD
    Lee, ST
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 2005, 82 (03) : 181 - 188
  • [7] Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors
    Kakurai, M
    Fujita, N
    Murata, S
    Furukawa, Y
    Demitsu, T
    Nakagawa, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (05) : 743 - 749
  • [8] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) - AN AMNESTIC NEUROPEPTIDE
    FLOOD, JF
    GARLAND, JS
    MORLEY, JE
    PEPTIDES, 1990, 11 (05) : 933 - 938
  • [9] EFFECTS OF VASOACTIVE-INTESTINAL-PEPTIDE ON MYOCARDIAL PERFORMANCE
    XENOPOULOS, NP
    APPLEGATE, RJ
    AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (02): : H399 - H405
  • [10] Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator
    Gonzalez-Rey, Elena
    Varela, Nieves
    Chorny, Alejo
    Delgado, Mario
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (11) : 1113 - 1139